Skip to main content
Jong Lee, MD, Family Medicine, Plymouth, MI

JongLeeMDCAQSM

Family Medicine Plymouth, MI

Sports Medicine (Non-Surgical)

Sports Medicine/Family Medicine

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lee's full profile

Already have an account?

  • Office

    40777 Ann Arbor Rd E
    Plymouth, MI 48170
    Phone+1 734-928-1600

Summary

  • I am board certified in Family Medicine and Sports Medicine. I have dual appointments in both Orthopedic Surgery and Family Medicine at Henry Ford

Education & Training

  • Henry Ford Health/Henry Ford Hospital
    Henry Ford Health/Henry Ford HospitalFellowship, Sports Medicine (Family Medicine), 2009 - 2010
  • Cedar Rapids Medical Education Foundation
    Cedar Rapids Medical Education FoundationResidency, Family Medicine, 2006 - 2009
  • Fatima College of Medicine
    Fatima College of MedicineClass of 2000

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • MI State Medical License
    MI State Medical License 2009 - 2025
  • IA State Medical License
    IA State Medical License 2006 - 2011
  • American Board of Family Medicine Family Medicine
  • American Board of Family Medicine Sports Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Press Mentions

  • Henry Ford Health Names Head Team Doctors for Two USFL Teams for the 2023 Season
    Henry Ford Health Names Head Team Doctors for Two USFL Teams for the 2023 SeasonApril 27th, 2023
  • Efficacy and Safety of Romiplostim in Refractory Aplastic Anaemia: A Phase II/III, Multicentre, Open‐Label Study
    Efficacy and Safety of Romiplostim in Refractory Aplastic Anaemia: A Phase II/III, Multicentre, Open‐Label StudyNovember 5th, 2020
  • Day Zero Diagnostics to Use $16M in Funding to Improve Management of Antibiotic-Resistant Infections
    Day Zero Diagnostics to Use $16M in Funding to Improve Management of Antibiotic-Resistant InfectionsSeptember 30th, 2023